Company Overview
HealthEquity, Inc. operates within the healthcare sector, specifically functioning in the health information services industry by providing technology-enabled services platforms to consumers and employers across the United States. The company's core offerings include health savings accounts, a dedicated investment platform, and online-only automated investment advisory services delivered through a web-based tool known as Advisor. This operational scope is supported by a substantial workforce of 2,814 employees, reflecting the labor intensity required to maintain complex digital financial and health data infrastructures. With a market capitalization of $7.02B and annual revenue reaching $1.31B, the company holds a significant valuation that indicates it is a large-cap entity with established market penetration. These financial figures suggest that HealthEquity has achieved a level of maturity where it generates multi-hundred-million dollar revenues while employing nearly three thousand individuals, positioning it as a major player in the digital health finance space.
Financial Health
The company reported revenue of $1.31B over the trailing twelve months, accompanied by net income of $215.20M and EBITDA of $482.14M. The substantial gap between the $1.31B revenue and the $215.20M net income reveals a robust cost structure, indicating that the company retains significant earnings after covering all operational expenses and taxes. Free cash flow stands at $338.05M, which provides the organization with considerable financial flexibility to fund operations, pursue strategic acquisitions, or manage capital expenditures without needing immediate external financing. Profitability is further evidenced by a gross margin of 69.5%, an operating margin of 21.6%, and a profit margin of 16.4%, all of which indicate efficient scaling of operations and effective cost management relative to revenue generation. On the balance sheet, the company holds $318.93M in cash against $1.00B in debt, resulting in a debt-to-equity ratio of 47.53%, which suggests a leveraged balance sheet where liabilities are more than half the size of shareholder equity. Despite the leverage, the current ratio of 3.27 indicates strong short-term liquidity, meaning the company possesses more than three times the assets needed to cover its current liabilities. Management effectiveness is highlighted by a return on equity of 10.2% and a return on assets of 6.0%, demonstrating that the company generates solid returns on the capital invested by shareholders and the total asset base.
Valuation Assessment
Valuation metrics show a trailing P/E ratio of 37.22 compared to a forward P/E of 15.40, implying that the market expects earnings to grow significantly in the coming year to bridge this wide disparity. The price-to-book ratio is recorded at 3.27, which indicates that the market values the company at more than three times its net asset book value, suggesting a premium for its intangible assets and growth prospects. Alternative valuation measures include a price-to-sales ratio of 5.34 and an EV/EBITDA of 15.63, which collectively suggest that investors are willing to pay a high multiple relative to both sales and earnings before interest, taxes, depreciation, and amortization. The stock's trading range over the past year spans from a 52-week low of $72.76 to a 52-week high of $116.65, providing a clear context for price volatility and historical performance boundaries. The beta of 0.32 indicates that the stock exhibits low price volatility relative to the broader market, moving with less intensity than the general equity index.
Growth & Income
Revenue growth stands at 7.3% year-over-year, while earnings growth reaches 92.4% year-over-year, indicating that earnings are expanding at a rate vastly superior to revenue. This divergence implies that the company is leveraging its existing revenue base to significantly boost profitability, likely through improved operational efficiency, margin expansion, or one-time adjustments. As a non-dividend payer, HealthEquity maintains a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests all of its earnings back into the business rather than distributing cash to shareholders. The overall growth and income profile reflects a classic growth equity strategy where capital retention drives future expansion rather than current income distribution.